Medical/Pharmaceuticals

Hebron Technology Co., Ltd. Reports Fiscal Year 2018 Financial Results

WENZHOU, China, May 15, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced its f...

2019-05-16 05:00 11006

Anpac Bio Gains U.S. CLIA Lab Certification

SACRAMENTO, California, May 16, 2019 /PRNewswire/ -- Dr. Chris Yu, Chief Executive Officer of international life sciences corporation,Anpac Bio-Medical Science Company (Anpac Bio), announced today that the company's United States subsidiary, Anpac TechnologyUSA, successfully passed the State of C...

2019-05-16 04:16 2294

Apollo Proton Cancer Centre, Chennai performs India's First Total Marrow Irradiation Procedure

CHENNAI, India, May 15, 2019 /PRNewswire/ -- In a first-ever milestone in cancer treatment inIndia, the Apollo Proton Cancer Center (APCC) in Chennai has successfully performed Total Marrow Irradiation (TMI) as a conditioning protocol prior to Bone Marrow Transplant.  

2019-05-15 22:46 2367

Collinson Continues Medical Assistance Expansion With Aspen Medical Partnership

Fully comprehensive assistance service for complex international deployment LONDON, May 15, 2019 /PRNewswire/ -- Collinson, an expert in global traveller assistance, has further enhanced its medical assistance capability through a partnership with Aspen Medical, an Australian-owned global healthc...

2019-05-15 22:28 3310

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

SYDNEY, May 15, 2019 /PRNewswire/ -- NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in t...

2019-05-15 20:13 1887

Connell broadens offering to its Life Science customers with the acquisition of Ingredient Resources

SAN FRANCISCO, May 15, 2019 /PRNewswire/ -- Connell, a Wilbur-Ellis company and a leading marketer and distributor of specialty chemicals and ingredients in Asia-Pacific, announces today the acquisition of Ingredient Resources Pty Limited, a supplier and distributor of innovative, valued-added ing...

2019-05-15 19:00 2759

China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results

HAIKOU, China, May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...

2019-05-15 18:00 8352

Ping An completes multi-center clinical trials for world's first intelligent OCT retinal disease screening system

SHANGHAI and HONG KONG, May 15, 2019 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. ("China Ping An", "Ping An", the "Group" or the "Company"; stock codes: HKEX 2318 and SSE 601318) is pleased to announce that its technology arm, Ping An Technology, has completed a prospective ...

2019-05-15 17:51 9219

Ping An Good Doctor and Wyeth Reached Strategic Cooperation

SHANGHAI, May 15, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK) announced strategic cooperation with Wyeth Nutrition on15 May 2019. Both sides will utilize their strengths in their respective fields for an all...

2019-05-15 15:20 5866

FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma

DARMSTADT, Germany and NEW YORK, May 15, 2019 /PRNewswire/ -- Not intended for US, Canada and UK-based media  * BAVENCIO is the first anti-PD-L1 in combination with axitinib approved by FDA for first-line treatment of patients with advanced renal cell carcinoma (RCC)  * Phase III study show...

2019-05-15 08:25 3581

Pneuma Respiratory and Leads Biolabs, Inc. Announce Partnership

BOONE, North Carolina, May 15, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc., developer of a proprietary breath-activated digital inhaler (BDI), and Leads Biolabs Inc. announce an agreement granting Pneuma an exclusive license to develop Leads Biolabs' panel of immuno-oncology monoclonal antibodi...

2019-05-15 07:53 2261

Sekisui Diagnostics Invests $1.9 million in Microbial Biopharma CDMO Business

LEXINGTON, Massachusetts, May 15, 2019 /PRNewswire/ -- Sekisui Diagnostics Enzyme business announces the completion of a newBioProcess Innovation Centre at the site in Maidstone, Kent by the end of 2019, following a$1.9 million investment. This investment is part of a long-term investment strateg...

2019-05-15 03:11 2212

BGI Genomics and Pryzm Health Form Strategic Partnership to Advance Precision Public Health

SHENZHEN, China, May 14, 2019 /PRNewswire/ -- BGI Genomics and digital health start-up, Pryzm Health (Pryzm), signed a Memorandum of Understanding (MoU) today for collaboration to advance precision public health in Australia.  With their complementary expertise and technology, BGI Genomics and Pr...

2019-05-14 17:04 4615

Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore

PALO ALTO, California and SINGAPORE, May 14, 2019 /PRNewswire/ -- At a ceremony inSingapore today, Varian (NYSE: VAR) announced, in partnership with Proton Therapy Pte., Ltd, the completion of the cyclotron installation for the Varian ProBeam® Compact single-room proton therapy system at Biopolis...

2019-05-14 12:15 9624

Covestro debuts future drug delivery concept in Asia at CMEF

SHANGHAI, May 14, 2019 /PRNewswire/ -- Covestro is today attending the China International Medical Equipment Fair (CMEF) spring show - the leading event in China's medical equipment industry. At the event, Covestro will debut its connected drug delivery concept inAsia and showcase solutions for...

2019-05-14 12:05 4755

Peritech Pharma Granted Patents for China and Russia

HERZLIYA, Israel, May 14, 2019 /PRNewswire/ -- Peritech Pharma , a specialty anal-rectal pharmaceutical company, today announced it has been granted patents coveringChina and Russia for its drug delivery platform used for two of its over-the-counter products, PP-110 f...

2019-05-14 08:55 3172

Brain imaging AI leader icometrix raises $18 million in new funding

Company's technology will transform care for patients with brain disorders and injuries LEUVEN, Belgium and GENEVA and BOSTON, May 14, 2019 /PRNewswire/ -- icometrix , the global expert in brain imaging Artificial Intelligence solutions, has raised$18 million through a partnership led by Forestay...

2019-05-14 08:00 3944

Ortho Clinical Diagnostics to Host 4th Annual Hospital C-Suite Summit in Singapore

2-Day Summit Will Bring Together Top Hospital Executives and Focus on Patient Safety and Service Excellence RARITAN, New Jersey and SINGAPORE, May 14, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, in collaboration withSingapore Management University, w...

2019-05-14 07:00 2683

Ortho Clinical Diagnostics to Host 4th Annual Hospital C-Suite Summit in Singapore

2-Day Summit Will Bring Together Top Hospital Executives and Focus on Patient Safety and Service Excellence RARITAN, New Jersey and SINGAPORE, May 14, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, in collaboration withSingapore Management University, w...

2019-05-14 07:00 2855

AirXpanders® Announces Special 510(k) Submission to the US FDA for a Smooth Shell Version of the AeroForm® Tissue Expander System

SAN JOSE, California, May 13, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP),  a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has submitted a Special 510(k) pre-market notification to t...

2019-05-14 04:09 1102